ERBB2 and breast cancer: Luminal-A tumours (58.5%) are the most prevalent subtype of breast cancer tumours, then triple-negative (16%), luminal-B (14%) and HER-2 positive (11.5%) being the least prevalent (Al-thoubaity, 2019).